205 related articles for article (PubMed ID: 3510799)
1. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
Cody RJ; Kubo SH; Covit AB; Müller FB; Rutman H; Leonard D; Laragh JH; Feldschuh J; Preibisz J
Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
[TBL] [Abstract][Full Text] [Related]
2. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
[TBL] [Abstract][Full Text] [Related]
3. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
4. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
Remme WJ; van Hoogenhuyze DC; Kruijssen HA; Pieper PG; Bruggeling WA
Cardiology; 1992; 80(2):132-42. PubMed ID: 1611632
[TBL] [Abstract][Full Text] [Related]
5. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
[TBL] [Abstract][Full Text] [Related]
6. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
7. Renal and hormonal effects of phosphodiesterase III inhibition in congestive heart failure.
Cody RJ
Am J Cardiol; 1989 Jan; 63(2):31A-34A. PubMed ID: 2642628
[TBL] [Abstract][Full Text] [Related]
8. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
Cody RJ; Müller FB; Kubo SH; Rutman H; Leonard D
Circulation; 1986 Jan; 73(1):124-9. PubMed ID: 3940663
[TBL] [Abstract][Full Text] [Related]
9. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
10. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
Levine TB; Olivari MT; Cohn JN
Am J Med; 1984 May; 76(5B):38-42. PubMed ID: 6375361
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
[TBL] [Abstract][Full Text] [Related]
14. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
Faxon DP; Creager MA; Halperin JL; Bernard DB; Ryan TJ
Am J Med; 1984 May; 76(5B):104-10. PubMed ID: 6203405
[TBL] [Abstract][Full Text] [Related]
15. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
[TBL] [Abstract][Full Text] [Related]
16. [Acute effect of milrinone on pulmonary hemodynamics in patients with hypoxic pulmonary hypertension].
Cheng D; Chen W; Jiang J
Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):256-9. PubMed ID: 7587607
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.
Anderson JL; Baim DS; Fein SA; Goldstein RA; LeJemtel TH; Likoff MJ
J Am Coll Cardiol; 1987 Apr; 9(4):711-22. PubMed ID: 3549837
[TBL] [Abstract][Full Text] [Related]
18. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
[TBL] [Abstract][Full Text] [Related]
19. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
20. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
Pamboukian SV; Carere RG; Webb JG; Cook RC; D'yachkova Y; Abel JG; Ignaszewski AP
J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
